Resident Evil 2 Vaccine Synthesis
Resident Evil 2 is a survival horror game developed and published by Capcom and released for the PlayStation in 1998. The player controls Leon S. Kennedy and Claire Redfield, who must escape Raccoon City after its citizens are transformed into zombies by a biological weapon two months after the events of the original Resident Evil.
Resident Evil 2
With Jill Valentine and Chris Redfield being the survivors from the mansion incident the S.T.A.R.S team was able to report everything about the hidden lab in the Arkley Forrest. But no one believed them. |
Soon after that, the trouble began. With the virus from the lab spreading out over all Raccoon City and surroundings. The Raccoon Police Department just recently added a rookie cop to the Raccoon City devision. Leon was on the way to his new job as he stumbled over flesheating zombies. First day in the job and everything will last on him, since no other police officer is left.. |
On the other side, Claire is searching for her lost brother Chris who most likely is somewhere in Europe. Her hopes led her to Raccoon City, because that was the point where they last met each other. Instead of clues on Chris' dissapereance, Claire just found a totally messed up Raccoon City with tons of ugly monsters and mutations.. |
Soon both characters team up to get out of this horror. Their first priority now is to stay alive.. |
Resident Evil 2 Characters
- Resident Evil 2 Lab Code – 1st run Greenhouse codes When you get to the Greenhouse Control Room, you’ll find a panel in the west part of the room that can be used to enter lab codes.
- Once the base vaccine has been prepared, set it in the vaccine synthesis machine located in the P-4 level experiment room. The machine is fully automated and only requires the user to push the sequence start switch. At this point, the program will run automatically and synthesis will be complete within approximately 10 seconds.
Resident Evil 2 Pc Download
|
Resident Evil 2 Vaccine Synthesis 2
Resident Evil 2 Enemies
|
Comments are closed.